Relenza (zanamivir) inhalation powder.
Relenza (zanamivir) inhalation powder. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.
This alert notifies health care providers of the potential for patient harm if a particular inhalation powder is reconstituted and incorrectly administered.